Klin Farmakol Farm. 2004;18(4):223-224

Analógy prostaglandínov v liečbe glaukómu

Zuzana Baťová, Magdaléna Kuželová, Pavel Švec
Katedra farmakológie a toxikológie, Farmaceutická fakulta UK, Bratislava

Keywords: glaucoma, prostaglandin analogues.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Baťová Z, Kuželová M, Švec P. Analógy prostaglandínov v liečbe glaukómu. Klin Farmakol Farm. 2004;18(4):223-224.

Článok rozoberá stále aktuálnu problematiku glaukómu a predstavuje nový farmakoterapeutický prístup v jeho liečbe. Popri klasickej liečbe betablokátormi, parasympatomimetikami a inhibítormi karboanhydrázy sa v nej stále častejšie začínajú uplatňovať nové, moderné liečivá zo skupiny analógov prostaglandínov. V súčasnosti máme pre liečbu glaukómu už aj na Slovensku dostupných niekoľko analógov prostaglandínu: latanoprost, bimatoprost a travoprost.

Kľúčové slová

glaukóm, analógy prostaglandínov.

PROSTAGLANDIN ANALOGUES IN THE TREATMENT OF GLAUCOMA

The goal of this article is to discuss the problematic of glaucoma and to introduce new pharmacological treatment of glaucoma. The initial drug treatment involves topical cholinergic agonists, beta blockers or carbonic anhydrase inhibitors. One of the most recent contributions to the theapeutic arsenal available for the treatment of glaucoma is a new class of drugs called prostaglandin analogues. Several agents in this class are now available in Slovakia: latanoprost, bimatoprost and travoprost.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rimoldi J. Focusing on glaucoma. Drug Topics 1999; 2 August: 67-76. www.drugtopics.com.
    2. Xanski JJ. Clinical Ophtalmology. 4th ed. Oxford: Butterworth-Heinemann, 2000: 185-187.
    3. Quigley HA.. Number of people with glaucoma worldwide. Br J Ophtalmol 1996; 80: 389-393. Go to original source... Go to PubMed...
    4. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology VIII. Classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 1994; 46: 205-229. Go to PubMed...
    5. Wienreb RN, Kashiwagi K, Kashiwagi F. Prostaglandins increase metalloproteinase activity in medium of human cilliary smooth muscle cells in vitro. Invest Ophtalmol Vis Sci 1997; 38: 2772-2780.
    6. Schacknow PN. Balancing power and control in glaucoma therapy. Ocular surgery news 2003; 3: 8-9.
    7. Parish RK, Palmberg P, Sheu WP. A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophtalmol 2003; 135(5): 688-703. Go to original source... Go to PubMed...
    8. Stjernschantz JW. From PGF2-Isopropyl Ester to Latanoprost, A review of the development of Xalatan. Invest Ophtalmol Vis Sci 2001; 42: 1134-1145.

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.